Cooper Cos Aktie News

SAN RAMON, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2024 financial results on Thursday, February 29, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

Cooper Companies has experienced high-single-digit growth in the contact lens industry and is expanding into the women's health business. COO holds a significant position in the contact lens market, accounting for around 23% of the total market share. The expansion into women's health could add another growth leg for the company and expand its total addressable market size.

SAN RAMON, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET.

SAN RAMON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Cooper Companies (Nasdaq: COO) announced today that it will hold its next annual meeting of stockholders on Tuesday, March 19, 2024. Stockholders of record as of the close of business on January 24, 2024, will be eligible to vote on matters presented in the Company's proxy statement, including electing its slate of directors.

Cooper Companies (NYSE: COO ) just reported results for the fourth quarter of 2023. Cooper Companies reported earnings per share of $3.47.

The Cooper Companies, Inc. (NASDAQ:COO ) Q4 2023 Earnings Conference Call December 7, 2023 5:00 PM ET Company Participants Kim Duncan - VP of IR & Risk Management Albert White - President and CEO Brian Andrews - CFO & Treasurer Conference Call Participants Jason Bednar - Piper Sandler Lawrence Biegelsen - Wells Fargo Jeffrey Johnson - Baird Jonathan Block - Stifel Craig Bijou - Bank of America ...

SAN RAMON, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2023.

SAN RAMON, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) announced today that its Board of Directors has appointed Lawrence E. Kurzius as an independent director, effective December 1, 2023. Kurzius has also been appointed to serve on the Audit Committee and Organization & Compensation Committee when he joins the Board.